The Victor Chang Heart Research Institute and the University of Western Australia have signed a new strategic partnership that will significantly boost heart disease research in WA and across the country.
The affiliation of the Victor Chang Cardiac Research Institute to UWA marks a new chapter for both organizations.
Professor Jason Kovacic, executive director of the Victor Chang Cardiac Research Institute, said the affiliation was the culmination of a long and proud history of collaboration.
“It is a proud day for the Institute and brings together the combined strengths of two world-renowned organizations who are committed to tackling Australia’s biggest killer – heart disease,” said Professor Kovacic.
Picture: Professor Livia Hool, Vice-Chancellor Professor Amit Chakma and Dr Lee Nedkoff.
“It also marks a major expansion for the Institute that will not only help the 100,000 West Australians hospitalized each year with cardiovascular disease, but will also improve the lives of people around the world.”
Cardiovascular disease is also responsible for 29% of deaths in WA.
UWA Vice-Chancellor Professor Amit Chakma said the University was delighted to partner with the Victor Chang Cardiac Research Institute to build much-needed research capacity in Western Australia.
“This affiliation reinforces our commitment to tackling cardiovascular disease and creating a better future for Western Australians and the rest of the nation,” said Professor Chakma.
In addition to affiliation, the Institute is also celebrating the opening of its second laboratory at UWA headed by Dr. Lee Nedkoff.
Dr. Nedkoff is a cardiovascular epidemiologist who conducts significant research on coronary heart disease and stroke and is part of a team investigating rheumatic heart disease, which disproportionately affects Aboriginal and Torres Strait Islander peoples. .
Dr. Nedkoff joins the Institute’s Prof. Livia Hool, Wesfarmers, UWA-VCCRI Chair in Cardiovascular Research, and has led a collaborative research program at UWA since 2013. Prof. Hool is working on a breakthrough preventive treatment for hypertrophic cardiomyopathy or cardiac hypertrophy syndrome.
Dr Nedkoff said: “This is a fantastic opportunity to help shape the future of heart disease research in Australia. The reputation of the Institute is well established in the promotion of new treatments and discoveries in the fight against heart disease.
“I am incredibly excited and honored to join the team and bring a new set of skills to the Institute which I hope will shed light on the true extent of cardiovascular disease in Western Australia, a state which has unique health issues.”